PLAT and androgen insensitivity syndrome: However, another study involving 299 AIS patients who received intravenous tissue plasminogen activator (IV-tPA) treatment found no significant difference in TCBI levels between the groups with good outcomes (mRS score: 0–2) and poor outcomes (mRS score: 3–6) 3 months after AIS (20).